
AliveCor
Advertisement
Articles by AliveCor


Beyond the Checkbox: How Rethinking Your Cardiac Monitoring Approach Can Dramatically Improve Trial Outcomes
ByAliveCor
AliveCor knows that cardiac safety is critical, with concerns often driving drug withdrawals from trials and the market. Our solutions go beyond compliance to boost regulatory trust, data integrity, and trial success. As the only company offering integrated 6L and 12L ECGs, we provide comprehensive monitoring—onsite and remotely—to meet complex cardiac requirements. Our innovative tools empower sponsors and CROs to control trial data, enabling faster, smarter decisions throughout the research lifecycle.

Webinar Date/Time: Mon, Dec 2, 2024 11:00 AM EST

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
Using AI and Tokenized Data to Match Patients to Protocols
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5

.png)



.png)



.png)
.png)
